DOI: 10.1007/s12020-024-04033-6 [Google Scholar] Nguyen DV, Linderholm A, Haczku A, Kenyon N
Due to their cost, however, coverage of GLP-1s for obesity treatment in Medicaid, ACA Marketplace plans, and most large employer firms remains limited, and GLP-1 coverage in Medicare for treatment of obesity is prohibited under current law
We recommend that you read labels, warnings and directions of all products before use and not rely solely on the information provided by iHerb.
Medicare and Medicaid Considerations: For those eligible for Medicare, particularly under Part D prescription drug plans, coverage may be similar to other medications requiring formulary inclusion and prior authorization
Compounded formulations may come at different concentrations than the brand-name product